Marks JL - Search Results

1

Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.

Marks JL, Broderick S, Zhou Q, Chitale D, Li AR, Zakowski MF, Kris MG, Rusch VW, Azzoli CG, Seshan VE, Ladanyi M, Pao W. Marks JL, et al. J Thorac Oncol. 2008 Feb;3(2):111-6. doi: 10.1097/JTO.0b013e318160c607. J Thorac Oncol. 2008. PMID: 18303429 Free article.

2

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.

Riely GJ, Kris MG, Rosenbaum D, Marks J, Li A, Chitale DA, Nafa K, Riedel ER, Hsu M, Pao W, Miller VA, Ladanyi M. Riely GJ, et al. Clin Cancer Res. 2008 Sep 15;14(18):5731-4. doi: 10.1158/1078-0432.CCR-08-0646. Clin Cancer Res. 2008. PMID: 18794081 Free PMC article.

3

KRAS mutations in non-small cell lung cancer.

Riely GJ, Marks J, Pao W. Riely GJ, et al. Proc Am Thorac Soc. 2009 Apr 15;6(2):201-5. doi: 10.1513/pats.200809-107LC. Proc Am Thorac Soc. 2009. PMID: 19349489 Review.

4

Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4.

Marks JL, McLellan MD, Zakowski MF, Lash AE, Kasai Y, Broderick S, Sarkaria IS, Pham D, Singh B, Miner TL, Fewell GA, Fulton LL, Mardis ER, Wilson RK, Kris MG, Rusch VW, Varmus H, Pao W. Marks JL, et al. PLoS One. 2007 May 9;2(5):e426. doi: 10.1371/journal.pone.0000426. PLoS One. 2007. PMID: 17487277 Free PMC article.

5

Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma.

Marks JL, Gong Y, Chitale D, Golas B, McLellan MD, Kasai Y, Ding L, Mardis ER, Wilson RK, Solit D, Levine R, Michel K, Thomas RK, Rusch VW, Ladanyi M, Pao W. Marks JL, et al. Cancer Res. 2008 Jul 15;68(14):5524-8. doi: 10.1158/0008-5472.CAN-08-0099. Cancer Res. 2008. PMID: 18632602 Free PMC article.

6

Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma.

Bean J, Riely GJ, Balak M, Marks JL, Ladanyi M, Miller VA, Pao W. Bean J, et al. Among authors: marks jl. Clin Cancer Res. 2008 Nov 15;14(22):7519-25. doi: 10.1158/1078-0432.CCR-08-0151. Clin Cancer Res. 2008. PMID: 19010870 Free PMC article.

7

EGFR mutant lung adenocarcinomas in patients with germline BRCA mutations.

Marks JL, Golas B, Kirchoff T, Miller VA, Riely GJ, Offit K, Pao W. Marks JL, et al. J Thorac Oncol. 2008 Jul;3(7):805. doi: 10.1097/JTO.0b013e31817e4664. J Thorac Oncol. 2008. PMID: 18594331 Free article. No abstract available.

8

Metastatic tumors of the lung.

MARKS JL. MARKS JL. Dis Chest. 1950 Jan;17(1):63-73, illust. doi: 10.1378/chest.17.1.63. Dis Chest. 1950. PMID: 15399335 No abstract available.

9

RETRACTED ARTICLE: An in vitro model for quantifying chemical transfer from fabric to and through skin.

Marks JL, Kissel JC, Shirai JH, Fenske R, Bondi CAM. Marks JL, et al. J Expo Sci Environ Epidemiol. 2019 Oct;29(6):864. doi: 10.1038/s41370-018-0047-8. Epub 2018 Jun 1. J Expo Sci Environ Epidemiol. 2019. PMID: 29855516 No abstract available.

10

Symptomatic lower limb large vessel vasculitis presenting as fever of unknown origin diagnosed on FDG-PET/CT.

Mujukian A, Kay M, Marks JL. Mujukian A, et al. Among authors: marks jl. BMJ Case Rep. 2018 Jan 26;2018:bcr2017224019. doi: 10.1136/bcr-2017-224019. BMJ Case Rep. 2018. PMID: 29374655 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page